NCT07183501 Combined Hystroscopic and Laparoscopic Repair of CS Scar Disorder
| NCT ID | NCT07183501 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assiut University |
| Condition | Cesarean Section Complications |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-06-01 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-06-01 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Combined hystroscopic and laparoscopic repair of symptomatic uterine Niche as new technique to maximize resolution of symptoms after niche repair with concomitant increase in RMT
Eligibility Criteria
Inclusion Criteria: * symptomatic uterine Niche :postmenstrual spotting Exclusion Criteria: * contraindications for endoscopy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07183501 clinical trial?
This trial is open to female participants only, aged 20 Years or older, up to 45 Years, studying Cesarean Section Complications. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07183501 currently recruiting?
Yes, NCT07183501 is actively recruiting participants. Contact the research team at Abdulrahmanrageh@med.aun.edu.eg for enrollment information.
Where is the NCT07183501 trial being conducted?
This trial is being conducted at Asyut, Egypt.
Who is sponsoring the NCT07183501 clinical trial?
NCT07183501 is sponsored by Assiut University. The trial plans to enroll 30 participants.